Navigation Links
Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
Date:9/14/2007

CHARLIE ROSE SCIENCE SERIES Episode #9 - HEART DISEASE September 19, 2007

NEW YORK, Sept. 14 /PRNewswire/ -- The following is being issued by Pfizer Inc:

WHAT: The upcoming episode of the Charlie Rose Science Series will

discuss the global burden of cardiovascular disease, the leading

cause of mortality worldwide. A panel of experts will explore the

biology and genetics of the disease, prevention and treatment, the

development of medical, surgical and interventional therapies, and

steps individuals can take toward a heart-healthy lifestyle.

WHO: Guests will include:

-- Steven E. Nissen, MD, MACC, Chairman of Cleveland Clinic

Department of Cardiovascular Medicine

-- Lori Mosca, MD, MPH, PhD, Director of Preventive Cardiology, New

York Presbyterian Hospital

-- Harlan Krumholz, MD, Harold H. Hines Junior Professor of Medicine

and Epidemiology and Public Health, Yale University School of

Medicine

-- Lance Becker, MD, Director of the Center for Resuscitation

Science at the University of Pennsylvania

WHEN: Begins Airing on September 19, 2007 on PBS stations. Check your

local PBS listings for show times.

DESCRIPTION:

The Charlie Rose Science Series sponsored by Pfizer Inc is an exploration of modern advances in scientific research, their contribution to our understanding of the world around us, and how science breakthroughs can be applied to improving human health.

Charlie Rose is joined in this effort by his co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University.

As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past epis
'/>"/>

SOURCE Pfizer Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Flat panel displays
2. Panel stresses drawing outside biotech firms to state
3. National stem-cell panel, including UW profs, urges close watch on research
4. Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters
5. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
6. VC trends, company progress discussed at Mason Wells portfolio meeting
7. Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths
8. State CIO discusses IT and government
9. Industry Veterans discuss the "next big thing"
10. Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment
11. Wisconsin Leaders Discuss Economic Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015  Guardant Health®, the ... abstracts highlighting the performance and clinical utility of ... for oral and poster presentations at the International ... World Conference on Lung Cancer. These abstracts were ... of California, Davis; the University of Chicago; Sarah ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... and additive manufacturing on Sept. 17, 2015 at 9am PST. The webinar will focus ... application. More popularly known as 3D printing, additive manufacturing is a broad term that ...
(Date:9/2/2015)... LIBERTYVILLE, Ill. (PRWEB) , ... ... ... a leading provider of regulatory compliance, quality systems, analytical testing, education and ... consulting firm with expertise in medical device products/processes development, design control, validation, ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cqsxmg/gene_therapy ) ... "Gene Therapy - Technologies, Markets and Companies" ... therapy are difficult to estimate as there is only ... in China since 2004. Gene ... estimates are based on epidemiology of diseases to be ...
Breaking Biology Technology:Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 2Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 3Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9 4Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 2Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 3Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2
... ... Akt/mTOR inhibitor -, JAMAICA ... has presented three presentations at the 2008,annual meeting of the ... P529 is a non-steroidal, synthetic, small molecule dual acting,anti-angiogenic ...
... DEERFIELD, Ill., April 15 , What and ... CHICAGO (Carotid,intima-media tHICkness in Atherosclerosis using pioGlitazOne) published,today ... thickness (CIMT) with ACTOS(R) (pioglitazone HCl) was,associated with ... when compared to glimepiride., The increased effect ...
... /PRNewswire/ - The acceptance of Peros, oral,delivery platform ... achievement by Benchmark Biolabs, a full service,biopharmaceutical product ... oversees the operation and,management of the Peros production ... biotechnology campus in Lincoln, NE., By obtaining ...
Cached Biology Technology:Paloma Pharmaceuticals to Present at the American Association for Cancer Research 2Paloma Pharmaceuticals to Present at the American Association for Cancer Research 3Paloma Pharmaceuticals to Present at the American Association for Cancer Research 4New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl) 2New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl) 3Another industry first enabled by Benchmark Biolabs - Peros' oral delivery platform and vaccine facility licensed by the USDA 2
(Date:8/26/2015)... 2015 The report "Multi-Factor Authentication (MFA) ... Application (Travel & Immigration, Government, Banking, Defense, Commercial Security, ... 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is expected ... a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ages ...
(Date:8/24/2015)... South Africa , August 24, 2015 ... Germany ,s largest biometrics manufacturer DERMALOG and its ... with the "2015 African Biometrics Company of the Year Award". ... Nigeria .   -Cross reference: ... http://www.presseportal.de/nr/8896 - On Thursday evening, in ...
(Date:8/20/2015)... 20, 2015 The wearable technology market ... active and healthy. However, wearable technology has the ... to help improve diagnostic capabilities and therapeutic outcomes. ... Wearable Technologies Conference 2015 , where ... wearables in healthcare.    "Over the ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... -- Sequella, Inc., a clinical-stage biopharmaceutical company focused ... potential, announced today that the U.S. Food and ... (EMEA) independently reviewed Sequella lead drug compound, SQ109, ... for the treatment of tuberculosis. SQ109 shows excellent ...
... October 22, 2007 (TORONTO) Height may point to ... released by the Centre for Addiction and Mental Health ... on average than males without a sexual attraction to ... A Journal of Research and Treatment, suggests that pedophiles ...
... collaboration, more than 200 medical and scientific journals ... relationship between poverty and human development. The initiative, ... presentations on seven of the journal articles which ... of Health on Monday, October 22, 2007. ...
Cached Biology News:Sequella receives US and EU orphan drug status for SQ109 for the treatment of TB 2Sequella receives US and EU orphan drug status for SQ109 for the treatment of TB 3200 journals join in theme issues on poverty and human development 2200 journals join in theme issues on poverty and human development 3200 journals join in theme issues on poverty and human development 4200 journals join in theme issues on poverty and human development 5
Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
... 5 ml CELLection Dynabeads (4.5 m) coated ... epithelial antigen EpCAM and DNase Releasing Buffer. ... of epithelial tumour cells directly from blood, ... can be enriched from bone marrow. Enriched ...
... Cy3 Ab Labeling Kit, 1 kit. ... CyDye fluorescent dyes. Conjugations are carried ... within 1 h. Dyes are packaged ... ensure consistent labelings. Category: Blotting & ...
PHOTOMAN DIRECT COPY CAMERA, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: